Professional Documents
Culture Documents
);>
------ --- -- --
-----//
~ Chronic problems in any of these areas may be reflected in a decreased growth rate.
Causes:
Normal growth is the result of several factors, such as
NUTRITION
--_.--------
GENETICS
HORMONES
2-Psychosocial Causes:
Maternal deprivation syndrome: This often occurs in association with emotional deprivation and/ or neglect. Psychological Dwarfism: Psychological stress, or psychiatric diseases can inhibit growth either by altering endocrine function, or by secondary effect on nutrition.
3-Malnutrition: Worldwide, malnutrition is probably the most common cause of growth failure. Poor weight gain is often associated with short stature in these patients
6-Syndromes
of Short Stature:
Skeletal dysplasia (bone and cartilage disorder) ~ Normal - sized trunk ~ Short arms ~ Short legs ~ Slightly enlarged head with a prominent forehead
Prader- Willi syndrome, Laurence Moon Beidle (obesity + delayed puberty + short stature+ .... ).
7-Prematurities retardation:
and intrauterine
growth
8-Medications (corticosteroids):
Steroid excess stops growth more quickly than weight gain.
Cushing Syndrome:
Either exogenous or endogenous excess glucocorticoids lead to decreased growth before obesity or other signs of Cushing's syndrome develop.
-Diabetes mellitus:
Poorly controlled type 1 DM causes slow growth, while well controlled patients are compatible with normal growth.
L-
Causes of GH Deficiency:
- Growth hormone deficiency Congenital Idiopathic Acquired (brain tumor- irradiation) - Growth hormone resistance (Laron)
~alamu,
=::::>
Pit;Hry
GH
__
GHBPs (IGFBP3)
--------------~------------
D
IGFl IGF2
Target issue ------
-----
./ The patient's stature, ./ growth rate, or ./ height adjusted for midparentral height is sufficiently decreased, the following approach will be done for the diagnosis of the etiology of short stature.
Birth size & weight - birth trauma Mental and physical development Dietary history in Symptoms of systemic diseases or drug intake
III
Evaluation of psychological factors Family heights and age of pubertal maturation other siblings
Physical Examination
Height:
-Upper segment, lower segment, arm span, and head circumference -When to consider that this child is short for age? -/ < Third percentile ./ More than 3.5 SO below the mean. -/ Relation to midparentral height < 2 SO -/ Growth velocity < 5 cm per year
j- ...
, ,, ,
,
:'_--,,-4-==...l.'-.j
I ..... i
;- .':X"'t".t ~.f".!l~I
k:r:l,,,. :~"l
f
I!
f f
'
,
I
F- .
Appearance Dysmorphic features (syndromes) Hypothyroid Cushingoid All systems must be examined.
Investigations:
Urine and stool analysis Serum electrolytes, calcium, blood glucose, renal and hepatic functions & ABG Complete blood count and sedimentation rate Serum free T4, and TSH
Imaging Studies:
X-rays of the left wrist (bone age) to compare with standard charts. Any bone age more than 2 SD above or below the mean for chronologic age is out of the normal range. An MRI , and C'T of the brain may be obtained in children with growth hormone deficiency to rule out a brain tumor.
Treatment
of Short Stature:
Early therapeutic intervention is important. Therapy should begin before the child's growth process is complete. Treatment is directed at the cause of growth failure. Hormone replacement therapy may be necessary in children with hypothyroidism or growth hormone deficiency
Treatment of Growth Hormone Deficiency Biosynthetic growth hormone at a dose of 0.1- 0.3 mg/kg/wk (3 ID/mg), se; during the period of active growth before epiphyseal fusion. Older children do not respond as younger children, and may require larger doses. GH will not increase growth rate without adequate nutrition and euthyroid state.
Monitoring GH Therapy
Determination of growth response (change in height) every 3-4 months Measurements of serum IGF1 and I GFBP3 levels every 3-6 months Screening for potential side effects Evaluation of compliance Consideration of dose adjustment according to the response
Side Effects of GH
Side effects of GH are minimal and rare
Pseudo tumor cerebri Slipped capital femoral epiphysis
DM
Recurrence of eNS tumor Development of leukemia Long term cancer risk Gynecomastia
THANK YOU